IL6 and cancer: Moreover, it is also well-known that IFN-γ acts as an important stimulus for skewing the Mφ phenotype into the M1 type, which exerts its anti-cancer efficacy through immune mediators, specifically iNOS, TNF, and IL-6 [43].